{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:29:55Z","timestamp":1790461795250,"version":"4.1.0"},"reference-count":168,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.jaci.2014.12.1908","type":"journal-article","created":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T07:17:01Z","timestamp":1423034221000},"page":"312-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["The future of biologics: Applications for food allergy"],"prefix":"10.1016","volume":"135","author":[{"given":"Rebecca N.","family":"Bauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monali","family":"Manohar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Jay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari C.","family":"Nadeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2014.12.1908_bib1","series-title":"The WAO white book on allergy","author":"Pawankar","year":"2013"},{"key":"10.1016\/j.jaci.2014.12.1908_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4168\/aair.2011.3.2.67","article-title":"The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma","volume":"3","author":"Zheng","year":"2011","journal-title":"Allergy Asthma Immunol Res"},{"issue":"suppl","key":"10.1016\/j.jaci.2014.12.1908_bib3","first-page":"S1","article-title":"Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel","volume":"126","author":"Boyce","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl\u00a01","key":"10.1016\/j.jaci.2014.12.1908_bib4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1710-1492-7-S1-S3","article-title":"Allergic rhinitis","volume":"7","author":"Small","year":"2011","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jaad.2013.10.010","article-title":"Guidelines of care for the management of atopic dermatitis","volume":"70","author":"Eichenfield","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib6","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.jaci.2007.09.029","article-title":"Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma\u2013summary report 2007","volume":"120","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib7","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nbt0708-743","article-title":"(Re)defining biopharmaceutical","volume":"26","author":"Rader","year":"2008","journal-title":"Nat Biotech"},{"key":"10.1016\/j.jaci.2014.12.1908_bib8","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nrd3792","article-title":"The potential of biologics for the treatment of asthma","volume":"11","author":"Pelaia","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaci.2014.12.1908_bib9","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1009705","article-title":"Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children","volume":"364","author":"Busse","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaci.2014.12.1908_bib10","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1215372","article-title":"Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria","volume":"368","author":"Maurer","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaci.2014.12.1908_bib11","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","article-title":"Dupilumab in persistent asthma with elevated eosinophil levels","volume":"368","author":"Wenzel","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2014.12.1908_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jaci.2013.11.020","article-title":"Food allergy: epidemiology, pathogenesis, diagnosis, and treatment","volume":"133","author":"Sicherer","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib13","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1542\/peds.2009-1210","article-title":"Food allergy among children in the United States","volume":"124","author":"Branum","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2014.12.1908_bib14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/14728214.2013.829039","article-title":"Emerging drugs for eosinophilic esophagitis","volume":"18","author":"Kern","year":"2013","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.jaci.2014.12.1908_bib15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jaip.2013.04.004","article-title":"Food protein-induced enterocolitis syndrome (FPIES): current management strategies and review of the literature","volume":"1","author":"Jarvinen","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2014.12.1908_bib16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.anai.2011.11.010","article-title":"The natural history of persistent peanut allergy","volume":"108","author":"Neuman-Sunshine","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib17","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1542\/peds.2011-1762","article-title":"Allergic reactions to foods in preschool-aged children in a prospective observational food allergy study","volume":"130","author":"Fleischer","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2014.12.1908_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1710-1492-10-25","article-title":"Multiple-allergen oral immunotherapy improves quality of life in caregivers of food-allergic pediatric subjects","volume":"10","author":"Otani","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coph.2014.07.003","article-title":"Modulation of immune responses by immunotherapy in allergic diseases","author":"Cavkaytar","year":"2014","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib20","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0140-6736(13)62301-6","article-title":"Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial","volume":"383","author":"Anagnostou","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2014.12.1908_bib21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaci.2013.09.043","article-title":"Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation","volume":"133","author":"Su\u00e1rez-Fueyo","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jaci.2013.11.007","article-title":"Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy","volume":"133","author":"Vickery","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaip.2012.10.009","article-title":"Peanut oral immunotherapy: is it ready for clinical practice?","volume":"1","author":"Sampson","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2014.12.1908_bib24","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jama.2013.2049","article-title":"Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review","volume":"309","author":"Lin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2014.12.1908_bib25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1172\/JCI45434","article-title":"Food allergy","volume":"121","author":"Wang","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2014.12.1908_bib26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature10863","article-title":"Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine","volume":"483","author":"McDole","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2014.12.1908_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/86373","article-title":"Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria","volume":"2","author":"Rescigno","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib28","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.gastro.2011.11.039","article-title":"Peyer's patch dendritic cells sample antigens by extending dendrites through M cell-specific transcellular pores","volume":"142","author":"Lelouard","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2014.12.1908_bib29","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1084\/jem.20070590","article-title":"A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism","volume":"204","author":"Coombes","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2014.12.1908_bib30","article-title":"Retinoic acid primes human dendritic cells to induce gut-homing, IL-10-producing regulatory T cells","author":"Bakdash","year":"2014","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib31","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1084\/jem.20070602","article-title":"Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid","volume":"204","author":"Sun","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2014.12.1908_bib32","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/1521-4141(200204)32:4<1109::AID-IMMU1109>3.0.CO;2-K","article-title":"Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches","volume":"32","author":"Spahn","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib33","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20131397","article-title":"Classical Flt3L-dependent dendritic cells control immunity to protein vaccine","volume":"211","author":"Anandasabapathy","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2014.12.1908_bib34","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1084\/jem.20042276","article-title":"TGF-\u03b21 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells","volume":"201","author":"Marie","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2014.12.1908_bib35","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.immuni.2008.02.017","article-title":"Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces","volume":"28","author":"Rubtsov","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2014.12.1908_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/cimm.1995.1094","article-title":"Effect of in\u00a0vivo depletion of CD4+ and CD8+ cells on the induction and maintenance of oral tolerance","volume":"163","author":"Barone","year":"1995","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2567.2006.02346.x","article-title":"NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL-10 and transforming growth factor beta, and by clonally deleting antigen-specific T\u00a0cells","volume":"118","author":"Kim","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2014.12.1908_bib38","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/all.12218","article-title":"Tolerogenic CX3CR1+ B cells suppress food allergy-induced intestinal inflammation in mice","volume":"68","author":"Liu","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2014.12.1908_bib39","doi-asserted-by":"crossref","first-page":"6688","DOI":"10.1073\/pnas.91.14.6688","article-title":"Induction of anergy or active suppression following oral tolerance is determined by antigen dosage","volume":"91","author":"Friedman","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2014.12.1908_bib40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/mi.2012.5","article-title":"Changes in antigen-specific T-cell number and function during oral desensitization in cow's milk allergy enabled with omalizumab","volume":"5","author":"Bedoret","year":"2012","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib41","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaci.2013.12.1037","article-title":"Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3)","volume":"133","author":"Syed","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib42","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jaci.2008.04.023","article-title":"T(H)2 adjuvants: implications for food allergy","volume":"121","author":"Berin","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib43","doi-asserted-by":"crossref","first-page":"8080","DOI":"10.1073\/pnas.96.14.8080","article-title":"IL-4 enhances proliferation and mediator release in mature human mast cells","volume":"96","author":"Bischoff","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2014.12.1908_bib44","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib45","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.4049\/jimmunol.141.7.2335","article-title":"IL-4 is required to generate and sustain in\u00a0vivo IgE responses","volume":"141","author":"Finkelman","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib46","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0091-6749(96)70195-1","article-title":"Eosinophil recruitment is associated with IL-5, but not with RANTES, twenty\u2013four hours after allergen challenge","volume":"97","author":"Sur","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1084\/jem.167.1.43","article-title":"Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors","volume":"167","author":"Yamaguchi","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2014.12.1908_bib48","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.4049\/jimmunol.152.3.1094","article-title":"IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells","volume":"152","author":"Punnonen","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib49","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1067\/mai.2001.118600","article-title":"IL-13 induces eosinophil recruitment into the lung by an IL-5\u2013 and eotaxin-dependent mechanism","volume":"108","author":"Pope","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib50","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1084\/jem.20052448","article-title":"Type 2 immunity is controlled by IL-4\/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system","volume":"203","author":"Voehringer","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2014.12.1908_bib51","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nm734","article-title":"Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma","volume":"8","author":"Kuperman","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2014.12.1908_bib52","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2014.12.1908_bib53","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1053\/j.gastro.2007.02.044","article-title":"Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene","volume":"132","author":"Torgerson","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2014.12.1908_bib54","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaci.2009.03.001","article-title":"Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion","volume":"123","author":"Miyara","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib55","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaci.2013.12.1045","article-title":"Food allergy: insights into etiology, prevention, and treatment provided by murine models","volume":"133","author":"Oyoshi","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib56","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/pai.12004","article-title":"Development of natural tolerance and induced desensitization in cow's milk allergy","volume":"24","author":"Savilahti","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaci.2008.09.051","article-title":"Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein","volume":"123","author":"Shreffler","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib58","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2012.04.021","article-title":"Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy","volume":"130","author":"Swamy","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib59","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-2222.2010.03462.x","volume":"40","author":"Scadding","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2014.12.1908_bib60","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nri2653","article-title":"Intestinal mucosal barrier function in health and disease","volume":"9","author":"Turner","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib61","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.dld.2006.06.012","article-title":"Intestinal permeability in patients with adverse reactions to food","volume":"38","author":"Ventura","year":"2006","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jaci.2014.12.1908_bib62","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaci.2012.08.002","article-title":"IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization","volume":"131","author":"Chu","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib63","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1084\/jem.20122332","article-title":"IL-25 simultaneously elicits distinct populations of innate lymphoid cells and multipotent progenitor type 2 (MPPtype2) cells","volume":"210","author":"Saenz","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2014.12.1908_bib64","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1038\/ncomms3847","article-title":"Skin thymic stromal lymphopoietin initiates Th2 responses through an orchestrated immune cascade","volume":"4","author":"Leyva-Castillo","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2014.12.1908_bib65","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jaci.2011.10.036","article-title":"Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity","volume":"129","author":"Kim","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib66","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0091-6749(99)70395-7","article-title":"Birch pollen\u2013related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens","volume":"104","author":"Reekers","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib67","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1542\/peds.101.3.e8","article-title":"Prevalence of IgE-mediated food allergy among children with atopic dermatitis","volume":"101","author":"Eigenmann","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2014.12.1908_bib68","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jaci.2014.07.033","article-title":"Filaggrin loss-of-function mutations are associated with food allergy in childhood and adolescence","volume":"134","author":"Venkataraman","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib69","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jaci.2014.08.011","article-title":"Peanut allergy: Effect of environmental peanut exposure in children with\u00a0filaggrin\u00a0loss-of-function mutations","volume":"134","author":"Brough","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib70","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jaci.2013.03.043","article-title":"Filaggrin gene mutation associations with peanut allergy persist despite variations in peanut allergy diagnostic criteria or asthma status","volume":"132","author":"Asai","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib71","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1084\/jem.20122762","article-title":"Lung dendritic cells induce migration of protective T cells to the gastrointestinal tract","volume":"210","author":"Ruane","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2014.12.1908_bib72","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/ACI.0b013e3283036a90","article-title":"Understanding the mechanisms of anaphylaxis","volume":"8","author":"Peavy","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib73","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1081-1206(10)61217-3","article-title":"Biphasic anaphylactic reactions","volume":"95","author":"Lieberman","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib74","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nri2072","article-title":"New developments in FcepsilonRI regulation, function and inhibition","volume":"7","author":"Kraft","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib75","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jaci.2010.05.017","article-title":"Peanut-induced intestinal allergy is mediated through a mast cell\u2013IgE\u2013Fc\u03b5RI\u2013IL-13 pathway","volume":"126","author":"Wang","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib76","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0091-6749(97)70033-2","article-title":"Expression of high-affinity IgE receptors (Fc\u03b5RI) on peripheral blood basophils, monocytes, and eosinophils in atopic and nonatopic subjects: relationship to total serum IgE concentrations","volume":"99","author":"Sihra","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib77","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jaci.2013.06.015","article-title":"Anaphylaxis: clinical patterns, mediator release, and severity","volume":"132","author":"Brown","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib78","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJMoa070030","article-title":"Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis","volume":"358","author":"Vadas","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2014.12.1908_bib79","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaci.2012.08.016","article-title":"Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis","volume":"131","author":"Vadas","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib80","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1038\/emm.2014.7","article-title":"New era for mucosal mast cells: their roles in inflammation, allergic immune responses and adjuvant development","volume":"46","author":"Kurashima","year":"2014","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jaci.2014.12.1908_bib81","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.jaci.2011.03.044","article-title":"Distinct immune\u00a0effector pathways contribute to the full expression of peanut-induced anaphylactic reactions in mice","volume":"127","author":"Arias","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib82","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1172\/JCI119255","article-title":"Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis","volume":"99","author":"Miyajima","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2014.12.1908_bib83","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature07204","article-title":"The development of allergic inflammation","volume":"454","author":"Galli","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2014.12.1908_bib84","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2217\/imt.13.93","article-title":"Food allergy diagnosis and therapy: where are we now?","volume":"5","author":"Syed","year":"2013","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jaci.2014.12.1908_bib85","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1189\/jlb.1105637","article-title":"Mechanistic analysis of experimental food allergen-induced cutaneous reactions","volume":"80","author":"Prescott","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib86","doi-asserted-by":"crossref","first-page":"G593","DOI":"10.1152\/ajpgi.90431.2008","article-title":"IL-4 regulates susceptibility to intestinal inflammation in murine food allergy","volume":"296","author":"Cardoso","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib87","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/all.12484","article-title":"Casein-specific IL-4- and IL-13-secreting T cells: a tool to implement diagnosis of cow's milk allergy","volume":"69","author":"Michaud","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2014.12.1908_bib88","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jaci.2010.02.038","article-title":"Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy","volume":"125","author":"Sicherer","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib89","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jaci.2010.12.1083","article-title":"Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization","volume":"127","author":"Kim","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib90","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1399-3038.2008.00815.x","article-title":"IL13 variants are associated with total serum IgE and early sensitization to food allergens in children with atopic dermatitis","volume":"20","author":"Zitnik","year":"2009","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib91","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jaci.2003.12.037","article-title":"Associations between specific serum IgE response and 6 variants within the genes IL4, IL13, and IL4RA in German children: the German Multicenter Atopy Study","volume":"113","author":"Liu","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib92","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(07)61600-6","article-title":"Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies","volume":"370","author":"Wenzel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2014.12.1908_bib93","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.200909-1448OC","article-title":"A\u00a0randomized, controlled, phase 2 study of AMG 317, an IL-4R\u03b1 antagonist, in patients with asthma","volume":"181","author":"Corren","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2014.12.1908_bib94","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaci.2014.12.1908_bib95","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/gut.2009.178558","article-title":"Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial","volume":"59","author":"Straumann","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2014.12.1908_bib96","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jaci.2006.09.007","article-title":"Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis","volume":"118","author":"Stein","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib97","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaci.2011.11.044","article-title":"Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial","volume":"129","author":"Spergel","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib98","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1172\/JCI72061","article-title":"Emerging therapies for food allergy","volume":"124","author":"Keet","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2014.12.1908_bib99","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4049\/jimmunol.1001348","article-title":"The TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-\u03b3","volume":"186","author":"Grela","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib100","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa052916","article-title":"Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis","volume":"355","author":"Creticos","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2014.12.1908_bib101","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jaci.2003.11.001","article-title":"Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response","volume":"113","author":"Tulic","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib102","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2249.2010.04106.x","article-title":"Tolerance induction after specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A\u00a0in children","volume":"160","author":"Rosewich","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib103","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jaci.2013.05.032","article-title":"Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen","volume":"133","author":"Patel","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib104","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2500\/aap.2011.32.3453","article-title":"Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen","volume":"32","author":"DuBuske","year":"2011","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2014.12.1908_bib105","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/eji.201242747","article-title":"TLR ligands of ryegrass pollen microbial contaminants enhance Th1 and Th2 responses and decrease induction of Foxp3hi regulatory T cells","volume":"43","author":"Mittag","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib106","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.4049\/jimmunol.1000083","article-title":"TLR2 agonists enhance CD8+Foxp3+ regulatory T cells and suppress Th2 immune responses during allergen immunotherapy","volume":"184","author":"Tsai","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib107","doi-asserted-by":"crossref","first-page":"e69438","DOI":"10.1371\/journal.pone.0069438","article-title":"Unlipidated outer membrane protein Omp16 (U-Omp16) from Brucella spp. as nasal adjuvant induces a Th1 immune response and modulates the Th2 allergic response to cow's milk proteins","volume":"8","author":"Ibanez","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2014.12.1908_bib108","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijbiomac.2013.06.017","article-title":"Oral administration of chitin and chitosan prevents peanut-induced anaphylaxis in a murine food allergy model","volume":"61","author":"Bae","year":"2013","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib109","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.4049\/jimmunol.1100608","article-title":"Antigen-fixed leukocytes tolerize Th2 responses in mouse models of allergy","volume":"187","author":"Smarr","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib110","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.4049\/jimmunol.178.4.2212","article-title":"Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis","volume":"178","author":"Turley","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib111","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaci.2014.06.036","article-title":"Allergens and the airway epithelium response: gateway to allergic sensitization","volume":"134","author":"Lambrecht","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib112","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fimmu.2013.00356","article-title":"Allergen recognition by innate immune cells: critical role of dendritic and epithelial cells","volume":"4","author":"Salazar","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib113","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ni805","article-title":"Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP","volume":"3","author":"Soumelis","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib114","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1385\/CRIAI:29:1:061","article-title":"Anti-CD23","volume":"29","author":"Rosenwasser","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib115","first-page":"90","article-title":"Intestinal epithelial cells express the CD23\/Fc epsilon RII molecule: enhanced expression in enteropathies","volume":"80","author":"Kaiserlian","year":"1993","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2014.12.1908_bib116","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1053\/j.gastro.2005.06.014","article-title":"CD23-mediated IgE transport across human intestinal epithelium: inhibition by blocking sites of translation or binding","volume":"129","author":"Tu","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2014.12.1908_bib117","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.gastro.2006.03.044","article-title":"Transcytosis of IgE-antigen complexes by CD23a in human intestinal epithelial cells and its role in food allergy","volume":"131","author":"Li","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2014.12.1908_bib118","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nri2273","article-title":"IgE in allergy and asthma today","volume":"8","author":"Gould","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib119","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/eji.201141668","article-title":"IL-33 links tissue cells, dendritic cells and Th2 cell development in a mouse model of asthma","volume":"41","author":"Eiwegger","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib120","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nm.3281","article-title":"Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis","volume":"19","author":"Noti","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2014.12.1908_bib121","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaci.2010.04.037","article-title":"Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis","volume":"126","author":"Sherrill","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib122","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.jaci.2014.01.021","article-title":"Exposure to food allergens through inflamed skin promotes intestinal food allergy through the thymic stromal lymphopoietin-basophil axis","volume":"133","author":"Noti","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib123","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1189\/jlb.1211622","article-title":"The multiple facets of thymic stromal lymphopoietin (TSLP) during allergic inflammation and beyond","volume":"91","author":"Roan","year":"2012","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib124","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa1402895","article-title":"Effects of an anti-TSLP antibody on allergen-induced asthmatic responses","volume":"370","author":"Gauvreau","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaci.2014.12.1908_bib125","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/intimm\/dxu058","article-title":"The role of basophils and proallergic cytokines, TSLP and IL-33, in cutaneously sensitized food allergy","volume":"26","author":"Muto","year":"2014","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib126","doi-asserted-by":"crossref","first-page":"G381","DOI":"10.1152\/ajpgi.00357.2012","article-title":"IL-33-induced alterations in murine intestinal function and cytokine responses are MyD88, STAT6, and IL-13 dependent","volume":"304","author":"Yang","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib127","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.4049\/jimmunol.1303026","article-title":"The immunology of food allergy","volume":"192","author":"Johnston","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib128","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jaci.2014.05.011","article-title":"IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice","volume":"134","author":"Li","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib129","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1398-9995.2011.02735.x","article-title":"Anti-IL-33 antibody has a therapeutic effect in a murine model of allergic rhinitis","volume":"67","author":"Kim","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2014.12.1908_bib130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbrc.2009.06.008","article-title":"Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma","volume":"386","author":"Liu","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jaci.2014.12.1908_bib131","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.coi.2014.08.001","article-title":"Targeting IgE production in mice and humans","volume":"31","author":"Wu","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib132","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jaci.2011.04.009","article-title":"Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy","volume":"127","author":"Nadeau","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib133","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jaci.2011.01.051","article-title":"A phase II, randomized, doubleblind, parallelgroup, placebocontrolled oral food challenge trial of Xolair (omalizumab) in peanut allergy","volume":"127","author":"Sampson","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib134","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2500\/aap.2010.31.3304","article-title":"Effects of omalizumab in patients with food allergy","volume":"31","author":"Rafi","year":"2010","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2014.12.1908_bib135","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jaci.2013.09.046","article-title":"A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients","volume":"132","author":"Schneider","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib136","doi-asserted-by":"crossref","first-page":"10474","DOI":"10.1021\/bi00033a020","article-title":"Characterization of complex formation by humanized anti-IgE monoclonal antibody and monoclonal human IgE","volume":"34","author":"Liu","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.jaci.2014.12.1908_bib137","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1111\/j.1398-9995.2009.02201.x","article-title":"Effects of omalizumab on markers of inflammation in patients with allergic asthma","volume":"64","author":"Holgate","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2014.12.1908_bib138","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaci.2004.06.032","article-title":"Omalizumab-induced reductions in mast cell Fc\u03b5RI expression and function","volume":"114","author":"Beck","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib139","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jaci.2003.11.044","article-title":"Omalizumab rapidly decreases nasal allergic response and Fc\u03b5RI on basophils","volume":"113","author":"Lin","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib140","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jaci.2003.10.003","article-title":"Omalizumab treatment downregulates dendritic cell Fc\u03b5RI expression","volume":"112","author":"Prussin","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib141","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaci.2009.10.021","article-title":"Decreases in human dendritic cell\u2013dependent TH2-like responses after acute in\u00a0vivo IgE neutralization","volume":"125","author":"Schroeder","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib142","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/72601","article-title":"The pharmacological basis of anti-IgE therapy","volume":"18","author":"Chang","year":"2000","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib143","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.dsi.2012.10.001","article-title":"The pharmacological mechanisms of omalizumab in patients with very high IgE levels\u2014clues from studies on atopic dermatitis","volume":"30","author":"Chang","year":"2012","journal-title":"Dermatologica Sinica"},{"key":"10.1016\/j.jaci.2014.12.1908_bib144","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.anai.2013.04.011","article-title":"Efficacy of omalizumab in asthmatic patients with IgE levels above 700 IU\/mL: a retrospective study","volume":"110","author":"Maselli","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib145","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/cea.12400","article-title":"Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects","volume":"44","author":"Arm","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2014.12.1908_bib146","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jaci.2006.09.040","article-title":"Relationship between spleen tyrosine kinase and phosphatidylinositol 5\u2032 phosphatase expression and secretion from human basophils in the general population","volume":"119","author":"MacGlashan","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib147","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.4049\/jimmunol.1102689","article-title":"Soluble CD23 controls IgE synthesis and homeostasis in human B cells","volume":"188","author":"Cooper","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib148","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jaci.2005.07.007","article-title":"Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects","volume":"116","author":"Poole","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib149","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0192-0561(99)00068-5","article-title":"In\u00a0vitro IgE inhibition in B cells by anti-CD23 monoclonal antibodies is functionally dependent on the immunoglobulin Fc domain","volume":"22","author":"Nakamura","year":"2000","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib150","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10735-013-9484-9","article-title":"In\u00a0vivo intranasal anti-CD23 treatment inhibits allergic responses in a murine model of allergic rhinitis","volume":"44","author":"Zhou","year":"2013","journal-title":"J Mol Histol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib151","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0091-6749(03)01861-X","article-title":"Allergic asthma and an anti-CD23 mAb (IDEC-152): results of a phase I, single-dose, dose-escalating clinical trial","volume":"112","author":"Rosenwasser","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib152","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4049\/jimmunol.148.1.129","article-title":"A new isoform of human membrane-bound IgE","volume":"148","author":"Peng","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib153","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1172\/JCI40141","article-title":"Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized mice","volume":"120","author":"Brightbill","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2014.12.1908_bib154","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.4049\/jimmunol.0902437","article-title":"Unique epitopes on C\u03b5mX in IgE\u2013B cell receptors are potentially applicable for targeting IgE-committed B cells","volume":"184","author":"Chen","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib155","doi-asserted-by":"crossref","first-page":"243ra85","DOI":"10.1126\/scitranslmed.3008961","article-title":"Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production","volume":"6","author":"Gauvreau","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2014.12.1908_bib156","doi-asserted-by":"crossref","first-page":"20850","DOI":"10.1074\/jbc.M110.113910","article-title":"Development of a two-part strategy to identify a therapeutic human bispecific antibody that inhibits IgE receptor signaling","volume":"285","author":"Jackman","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2014.12.1908_bib157","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1398-9995.2011.02546.x","article-title":"Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein","volume":"66","author":"Eggel","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2014.12.1908_bib158","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.clim.2005.12.010","article-title":"A chimeric human-cat Fc\u03b3-Fel d1 fusion protein inhibits systemic, pulmonary, and cutaneous allergic reactivity to intratracheal challenge in mice sensitized to Fel d1, the major cat allergen","volume":"120","author":"Terada","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib159","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm1219","article-title":"A chimeric human-cat fusion protein blocks cat-induced allergy","volume":"11","author":"Zhu","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2014.12.1908_bib160","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jaci.2012.10.018","article-title":"Blockade of peanut allergy with a novel Ara h 2\u2013Fc\u03b3 fusion protein in mice","volume":"131","author":"Liu","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib161","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jaci.2013.10.054","article-title":"Specific immunotherapy modifies allergen-specific CD4+ T-cell responses in an epitope-dependent manner","volume":"133","author":"Wambre","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib162","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jaci.2014.05.042","article-title":"Oral immunotherapy induces IgG antibodies that act through Fc\u03b3RIIb to suppress IgE-mediated hypersensitivity","volume":"134","author":"Burton","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib163","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.4155\/fmc.13.112","article-title":"Development of small molecules to target the IgE: Fc\u03b5RI protein\u2013protein interaction in allergies","volume":"5","author":"Smith","year":"2013","journal-title":"Future Med Chem"},{"key":"10.1016\/j.jaci.2014.12.1908_bib164","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nature11546","article-title":"Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor","volume":"491","author":"Kim","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2014.12.1908_bib165","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.jaci.2014.02.005","article-title":"Accelerated\u00a0dissociation of IgE-Fc\u03b5RI complexes by disruptive inhibitors actively\u00a0desensitizes allergic effector cells","volume":"133","author":"Eggel","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib166","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.immuni.2014.05.017","article-title":"Immunoglobulin E signal inhibition during allergen ingestion leads to reversal of established food allergy and induction of regulatory T cells","volume":"41","author":"Burton","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2014.12.1908_bib167","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1067\/mai.2002.123302","article-title":"Pathways of anaphylaxis in the mouse","volume":"109","author":"Strait","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1908_bib168","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jaci.2013.02.043","article-title":"Rapid polyclonal desensitization with antibodies to IgE and Fc\u03b5RI\u03b1","volume":"131","author":"Khodoun","year":"2013","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674914037087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674914037087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:50:45Z","timestamp":1758790245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674914037087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":168,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0091674914037087"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2014.12.1908","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The future of biologics: Applications for food allergy","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2014.12.1908","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}